Zhongnan Medical Journal Press

Home Results

A total of 6 result was found. Results that relate to ZHANG Xiaoqi

A case of ischemic colitis after colonic endoscopic submucosal dissection

Published on New Medicine 2022,32(1):69-73.
14373 times 4620 times

ZHANG Lu ZHANG Xiaoqi YE Xiaofeng

Endoscopic submucosal dissection Ischemic colitis Case report
Details
Quality difference evaluation of Radix tetrastigmae based on quantitative analysis of multi-components by single-marker, chemometrics and entropy weight-technique for order preference by similarity to ideal solution method

Published on Frontiers in Pharmaceutical Sciences 2024,27(3):365-375.
11606 times 2490 times

XIANG Yan HU Zhen SUN Liang ZHANG Xiaoqin

Radix tetrastigmae Quantitative analysis of multi-components by single- marker Chemometrics Entropy weight-technique for order preference by similarity to ideal solution Quality difference evaluation
Details
Efficacy and safety of trastuzumab deruxtecan in the treatment of breast cancer: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(5):539-548.
12401 times 2923 times

ZHANG Xiaoqing LIU Shuai ZHANG Kai LUAN Wei

Trastuzumab deruxtecan Antibody drug conjugates Breast cancer Efficacy Safety Meta-analysis Randomized controlled trial
Details
Clinical progress of cadonilimab in the treatment of malignant tumor

Published on New Medicine 2025,35(6):708-715.
21687 times 3793 times

ZHANG Xiaoqing LIU Shuai ZHANG Kai WANG Yuchao HE Jing LUAN Wei

Cadonilimab Bispecific antibody Immunotherapy Tumors
Details
Progress of gut microbiota in tumor immunotherapy

Published on New Medicine 2025,35(9):1099-1107.
15037 times 1932 times

ZHANG Xiaoqing SU Rina LIU Shuai ZHANG Kai HE Jing WANG Yuchao LUAN Wei

Gut microbiota Immune system Immune checkpoint inhibitors Tumour therapy
Details
Efficacy evaluation and quality of life analysis of cadonilimab combined with bevacizumab biosimilar and chemotherapy in the treatment of metastatic colorectal cancer

Published on Frontiers in Pharmaceutical Sciences 2026,30(9):1538-1548.
668 times 172 times

ZHANG Xiaoqing LIU Shuai ZHANG Kai HE Jing WANG Yuchao ZHANG Juan LUAN Wei

Cadonilimab Bevacizumab Metastatic colorectal cancer Efficacy evaluation RAS-mutated Progression-free survival Objective response rate Disease control rate
Details